Dimensional Fund Advisors
RCUS icon

Dimensional Fund Advisors’s Arcus Biosciences RCUS Stock Holding History

Dimensional Fund Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.8M Sell
1,426,223
-97,934
-6% -$2.12M 0.01% 1757
2025
Q4 		$36.3M Buy
1,524,157
+21,694
+1% +$443K 0.01% 1678
2025
Q3 		$20.4M Sell
1,502,463
-157,416
-9% -$1.64M ﹤0.01% 1984
2025
Q2 		$13.5M Sell
1,659,879
-62,204
-4% -$531K ﹤0.01% 2150
2025
Q1 		$13.5M Buy
1,722,083
+19,781
+1% +$229K ﹤0.01% 2121
2024
Q4 		$25.3M Buy
1,702,302
+178,351
+12% +$2.91M 0.01% 1886
2024
Q3 		$23.3M Buy
1,523,951
+44,324
+3% +$699K 0.01% 1936
2024
Q2 		$22.5M Sell
1,479,627
-141,782
-9% -$2.29M 0.01% 1906
2024
Q1 		$30.6M Buy
1,621,409
+26,800
+2% +$463K 0.01% 1762
2023
Q4 		$30.5M Buy
1,594,609
+158,094
+11% +$2.53M 0.01% 1759
2023
Q3 		$25.8M Buy
1,436,515
+297,035
+26% +$5.97M 0.01% 1781
2023
Q2 		$23.1M Sell
1,139,480
-167,597
-13% -$3.19M 0.01% 1858
2023
Q1 		$23.8M Buy
1,307,077
+312,887
+31% +$5.98M 0.01% 1807
2022
Q4 		$20.6K Buy
994,190
+314,096
+46% +$8.64M 0.01% 1858
2022
Q3 		$17.8M Buy
680,094
+359,339
+112% +$9.5M 0.01% 1893
2022
Q2 		$8.13M Sell
320,755
-117,214
-27% -$2.87M ﹤0.01% 2279
2022
Q1 		$13.8M Buy
437,969
+190,527
+77% +$6.38M ﹤0.01% 2154
2021
Q4 		$10M Buy
247,442
+208,543
+536% +$8.09M ﹤0.01% 2303
2021
Q3 		$1.36M Buy
38,899
+4,099
+12% +$128K ﹤0.01% 2973
2021
Q2 		$956K Buy
+34,800
New +$994K ﹤0.01% 3034
2021
Q1 		– Sell
-198,754
Closed -$5.16M – 3423
2020
Q4 		$5.16M Sell
198,754
-124,284
-38% -$3.01M ﹤0.01% 2514
2020
Q3 		$5.54M Buy
323,038
+89,294
+38% +$1.99M ﹤0.01% 2419
2020
Q2 		$5.78M Sell
233,744
-909
-0.4% -$24.5K ﹤0.01% 2429
2020
Q1 		$3.26M Buy
234,653
+45,937
+24% +$571K ﹤0.01% 2557
2019
Q4 		$1.91M Buy
188,716
+120,656
+177% +$1.01M ﹤0.01% 2864
2019
Q3 		$619K Buy
+68,060
New +$547K ﹤0.01% 3108

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Dimensional Fund Advisors's RCUS Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Arcus Biosciences (RCUS) stake by 6.4% in Q1 2026, selling an estimated $2.12M and leaving 1,426,223 shares worth $30.8M. The position accounts for 0.01% of the portfolio, ranked #1757.

Dimensional Fund Advisors first reported a position in RCUS in Q3 2019 and has held it in 26 quarters since. The position peaked at $36.3M in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Dimensional Fund Advisors held 1,426,223 shares of Arcus Biosciences worth $30.8M as of Q1 2026.
  • Dimensional Fund Advisors sold 97,934 Arcus Biosciences shares in Q1 2026, an estimated $2.12M.
  • Arcus Biosciences made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1757 holding.
  • Dimensional Fund Advisors first reported a position in Arcus Biosciences in Q3 2019 and has held it in 26 quarters since.
  • Dimensional Fund Advisors's Arcus Biosciences position peaked at $36.3M in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.